NFC
RLYB icon

Northeast Financial Consultants’s Rallybio RLYB Stock Holding History

Northeast Financial Consultants’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,053
Closed -$92.6K – 290
2024
Q4 		$92.6K Buy
12,053
+9,292
+337% +$77.9K ﹤0.01% 281
2024
Q3 		$25.8K Hold
2,761
– – ﹤0.01% 290
2024
Q2 		$29.6K Hold
2,761
– – ﹤0.01% 272
2024
Q1 		$40.9K Buy
+2,761
New +$38.5K ﹤0.01% 287
2023
Q4 		– Sell
-2,269
Closed -$61.2K – 286
2023
Q3 		$61.2K Hold
2,269
– – ﹤0.01% 280
2023
Q2 		$103K Buy
2,269
+636
+39% +$31.2K 0.01% 279
2023
Q1 		$74.6K Hold
1,633
– – ﹤0.01% 308
2022
Q4 		$85.8K Hold
1,633
– – 0.01% 312
2022
Q3 		$189K Buy
+1,633
New +$145K 0.01% 314

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Northeast Financial Consultants's RLYB Position: Q1 2025 in Review

Northeast Financial Consultants sold out of Rallybio (RLYB) in Q1 2025, closing a stake of 12,053 shares — an estimated $92.6K sold.

Northeast Financial Consultants first reported a position in RLYB in Q3 2022 and held it in 9 quarters. The position peaked at $189K in Q3 2022. 47 funds tracked by Wall St. Rank hold RLYB as of Q1 2025.

  • Northeast Financial Consultants reported no remaining Rallybio position as of Q1 2025 after selling out during the quarter.
  • Northeast Financial Consultants sold 12,053 Rallybio shares in Q1 2025, an estimated $92.6K.
  • Northeast Financial Consultants first reported a position in Rallybio in Q3 2022 and held it in 9 quarters.
  • Northeast Financial Consultants's Rallybio position peaked at $189K in Q3 2022.
  • 47 funds tracked by Wall St. Rank held Rallybio as of Q1 2025.

Based on Northeast Financial Consultants's 13F filing for Q1 2025, filed 16 May 2025.